Clinical Trial Update: 1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients [Phase 4]

View source ↗

Summary

Phase 4 trial comparing 1 week versus 6 weeks of levetiracetam in patients with surgical brain tumors; results completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Cancer
• Brain Neoplasms
• Brain Tumors

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: University of Florida | Conditions: Brain Neoplasms, Brain Cancer | Phase 4 | Status: COMPLETED | Results posted: 2021-12-15